A focussed research programme has
developed Allogran-R, a highly consistent, polycrystalline
and porous ฿ tri-calcium phosphate bone substitute.
Biocomposites' proprietary process
provides a synthetic and multiporous granular matrix with
outstanding biocompatibility.
Allogran-R, ฿ tri-calcium phosphate is
fully resorbed through dissolution and cell mediation to be
replaced by new bone.
Extensive research has shown a complete
non-toxic and favourable immunological reaction to the ฿
tri-calcium phosphate.
Studies also show its conversion
in-vivo to hydroxyapatite - the mineral constituent of
natural bone.
Early cases of delayed union have shown
Allogran-R to fully resorb concurrently with its replacement
by new bone.
KEY ADVANTAGES
Engineered porosity for complete
resorption
Osteoconductive
Proven biocompatibility
No risk of disease transmission or antigenicity
Elimination of donor site morbidity
INDICATIONS
To fill a bone defect caused by
Delayed union or non-union
Removal of a tumour or cyst
Trauma
Osteomyelitis
Spinal Cases
